Bristol-Myers Squibb Company is a company in the U.S. stock market and it is a holding in 241 U.S.-traded ETFs. BMY has around 175.0M shares in the U.S. ETF market. The largest ETF holder of BMY is the SPDR S&P 500 ETF Trust (SPY), with approximately 23.05M shares. Investors may also find of interest that the ETF with the largest allocation to BMY stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 8.41%. On average, U.S. ETFs allocate 0.88% of BMY to their portfolios.
Additionally, BMY is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BMY as a holding is the iShares Morningstar U.S. Equity ETF (ILCB), with a return of 498.40%.